Drug database provider First DataBank to join the Health 2.0 Accelerator consortium

First DataBank, a leading provider of integrated drug databases for the healthcare industry, today announced that it will join PharmaSURVEYOR and a growing list of "Health 2.0 companies" as participants in the Health 2.0 Accelerator, a consortium focused on promoting integration of technology and the consumer experience to advance consumer-centric health care.

In addition, First DataBank announced that it has partnered with PharmaSURVEYOR, a founding member of the Health 2.0 Accelerator (H2A), to launch a pilot project for direct online access to the company’s proprietary drug information and standardized drug codes. The Drug Code Lookup Service (DCLS) will provide Web developers with easy online access to First DataBank’s standardized drug codes with the aim to promote interoperability among Internet-based healthcare services and the portability of patient records across healthcare providers.

“We’re excited to work with PharmaSURVEYOR and H2A to make reliable up-to-date drug information available and affordable to this emerging ecosystem of patient-centric healthcare technologies,” said Don Nielsen, MD, president, First DataBank. “It is our intention that this pilot program will facilitate ease of information exchange so that ultimately the healthcare consumer can easily access the information they need to make informed health care decisions or improve the health care they receive.”

Drug codes accessed through the DCLS are provided from First DataBank’s National Drug Data File (NDDF™) Plus, one of the healthcare industry’s most widely used sources of up-to-date drug information utilized at the point of care. PharmaSURVEYOR will provide online access to NDDF Plus codes through Web services using a pay-per-use pricing model.

"The Drug Code Lookup Service couples the highest standards of drug data curation with the access, ease of use and limitless scalability of Web 2.0," said Erick Von Schweber, Executive co-chair of PharmaSURVEYOR, Inc.

The partnership between First DataBank and PharmaSURVEYOR also illustrates a key focus of the Health 2.0 Accelerator consortium: collaboration. H2A works with its participants to encourage collaboration around specific business or technical objectives to benefit consumers in ways that are challenging or inefficient for companies to tackle alone. For established health care companies, such as First DataBank, H2A provides an opportunity to collaborate with Health 2.0 companies and pursue innovative solutions for empowering patients to more actively engage in managing their health.

“We see this partnership as a potential model for how innovative Health 2.0 companies like PharmaSURVEYOR and seasoned health IT leaders like First DataBank can come together as H2A participants to make reliable data and powerful tools available to the community,” said Julie Murchinson, executive director of the Health 2.0 Accelerator.

The DCLS pilot will be highlighted during the Health 2.0 Conference in San Francisco, on October 7, 2009, and will be made available by PharmaSURVEYOR to members of the Health 2.0 Accelerator. The pilot program is the first in a series of offerings to make drug data available through online services. Following the pilot program, general availability of the Drug Code Lookup Service is planned for early 2010.

Source:

 First DataBank

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Squid-inspired technology could replace needles for medications and vaccines